No Data
No Data
No Data
No Data
No Data
Polycythemia Pipeline Insight 2024, Featuring Protagonist Therapeutics, Ionis Pharmaceuticals, Perseus Proteomics, Kartos Therapeutics, Imago BioSciences, Incyte, Italfarmaco, Lynk and Promedior
Yahoo FinanceApr 18 03:53 ET
Express News | Turnstone Biologics Appoints William Waddill to Its Board of Directors
Moomoo 24/7Apr 16 09:00 ET
Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Business Is Trailing The Industry But Its Shares Aren't
You may think that with a price-to-sales (or "P/S") ratio of 26.3x Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is a stock to avoid completely, seeing as almost half of all the Biotechs companies in t
Simply Wall StApr 13 10:01 ET
Hemochromatosis Pipeline Insight Report 2024, Featuring Protagonist Therapeutics, Sirnaomics and Bond Biosciences
Yahoo FinanceApr 11 09:31 ET
All You Need to Know About Protagonist Therapeutics (PTGX) Rating Upgrade to Buy
Yahoo FinanceApr 5 12:00 ET
Protagonist Therapeutics Inc CEO Sells 25,000 Shares
Yahoo FinanceApr 3 01:52 ET
No Data
No Data